These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7785262)

  • 1. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
    Dahlbäck B
    J Lab Clin Med; 1995 May; 125(5):566-71. PubMed ID: 7738422
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
    Weitz IC; Israel VK; Liebman HA
    Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V].
    Levoir D; Aubertin JM; Alhenc-Gelas M; Bloch F; Becheur H; Petite JP
    Gastroenterol Clin Biol; 1995; 19(8-9):729-31. PubMed ID: 8522125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 11. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.
    Greengard JS; Eichinger S; Griffin JH; Bauer KA
    N Engl J Med; 1994 Dec; 331(23):1559-62. PubMed ID: 7969326
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple and rapid detection of factor V Leiden by allele-specific PCR amplification.
    Blasczyk R; Ritter M; Thiede C; Wehling J; Hintz G; Neubauer A; Riess H
    Thromb Haemost; 1996 May; 75(5):757-9. PubMed ID: 8725719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retinal vein occlusion and resistance to activated protein C].
    Scat Y; Morin Y; Morel C; Haut J
    J Fr Ophtalmol; 1995; 18(12):758-62. PubMed ID: 8745708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden mutation: an unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis.
    Thorarensen O; Ryan S; Hunter J; Younkin DP
    Ann Neurol; 1997 Sep; 42(3):372-5. PubMed ID: 9307261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Q 506 mutation in children with thrombosis.
    Gurgey A; Mesci L; Renda Y; Olcay L; Kocak N; Erdem G
    Am J Hematol; 1996 Sep; 53(1):37-9. PubMed ID: 8813095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.